14 studies found for:    AMG785
Show Display Options
Rank Status Study
1 Completed Study of AMG 785 in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing
Condition: Fracture Healing
Interventions: Drug: AMG 785 210mg;   Drug: AMG 785 70mg;   Drug: AMG 785 140 mg;   Drug: Placebo
2 Active, not recruiting Phase 2 Study of AMG 785 in Postmenopausal Women With Low Bone Mineral Density
Conditions: Low Bone Mineral Density;   Postmenopausal Osteoporosis
Interventions: Drug: Active Comparator Alendronate;   Drug: Placebo;   Drug: AMG 785;   Drug: Active comparator teriparatide;   Drug: Denosumab;   Drug: Zoledronic acid
3 Completed Study To Assess Fracture Healing With Sclerostin Antibody
Condition: Fracture Healing
Interventions: Drug: Placebo;   Drug: AMG 785 140 mg;   Drug: AMG785 70mg;   Drug: AMG 785 210mg
4 Completed Study of Romosozumab (AMG 785) Administered to Healthy Subjects and Subjects With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring Hemodialysis
Condition: Osteoporosis
Intervention: Drug: Romosozumab
5 Completed A Single-dose Study Evaluating AMG 785 in Healthy Postmenopausal Japanese Women
Condition: Osteopenia
Interventions: Drug: AMG 785;   Drug: PLACEBO
6 Completed Transition From Alendronate to AMG 785
Condition: OSTEOPOROSIS, POSTMENOPAUSAL
Interventions: Drug: AMG 785 Dose 1;   Drug: AMG 785 Dose 2
7 Completed A First-in-human Study Evaluating AMG 785 in Healthy Men and Postmenopausal Women
Condition: Osteopenia
Interventions: Drug: AMG 785;   Drug: Placebo
8 Completed A Study to Evaluate the Effect of AMG 785 on Bone Quality of the Forearm in Postmenopausal Women With Low Bone Mass
Condition: Osteopenia
Interventions: Drug: AMG 785;   Drug: Placebo
9 Completed A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 785
Conditions: Postmenopausal;   Osteopenia
Interventions: Drug: Treatment Interval 1;   Drug: Treatment Interval 2
10 Active, not recruiting A Randomized Phase 3 Study to Evaluate 2 Different Formulations of Romosozumab in Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Romosozumab;   Drug: Placebo
11 Active, not recruiting Study With AMG 785 to Treat Japanese Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis (PMO)
Interventions: Drug: AMG 785;   Drug: Placebo
12 Recruiting An Open-label Study to Evaluate the Effect of Treatment With AMG 785 or Teriparatide in Postmenopausal Women (STRUCTURE)
Condition: Postmenopausal Osteoporosis
Interventions: Drug: AMG 785;   Drug: Teriparatide (TPTD)
13 Active, not recruiting Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: AMG 785;   Drug: Placebo
14 Recruiting Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Women With Osteoporosis
Interventions: Drug: Romosozumab;   Drug: Alendronate

Indicates status has not been verified in more than two years